Ulcerative Colitis: the What, When, and Why of Treatment

Ulcerative Colitis: the What, When, and Why of Treatment

 

Accreditation | Agenda | Faculty | Registration

 

Agenda

6:00pm
Registration and Dinner

6:45pm
Welcome and Overview

7:00pm
Screening, Treating, and Monitoring Ulcerative Colitis
Using a case-based format, several of the following topics will be discussed:

  • Use of 5-ASAs and budesonide for mild-to-moderate UC
  • Use of immunomodulators for moderate UC, including methotrexate, 6-MP, azathioprine
  • Use of biologic agents for moderate-to-severe UC
  • Overview of data: maintenance studies
  • Biologic agents therapy safety: the pros and cons of use and specific side effects
  • Minimizing complications of biological therapy

8:15pm
Evaluation

8:30pm
Adjourn